clinical trial · NCT04537832
Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies
Dravet SyndromeNo Intervention
brief summary
This is a multicenter, prospective, 2-year observational study in infants and children with developmental and epileptic encephalopathies (DEEs). The DEE currently being investigated is SCN1A-positive Dravet Syndrome.
started
Jan 18, 2021
primary completion
Mar 31, 2023
completion
Mar 31, 2023
last updated
Jun 12, 2023
detailed description
This prospective, longitudinal, natural history master protocol has been designed to define the seizure, neurodevelopmental, and behavioral characteristics of SCN1A-positive Dravet Syndrome in infants and children between 6 and 60 months. It will also explore the impact of the disease on the participant's parent/caregiver quality of life (QoL) and healthcare resource utilization (HCRU).
official title
ENVISION: Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol